These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Synthetic cannabinoids to avoid urine drug screens: Implications for contingency management and other treatments for drug dependence. Ninnemann AL, Lechner WV, Borges A, Lejuez CW. Addict Behav; 2016 Dec; 63():72-3. PubMed ID: 27424166 [Abstract] [Full Text] [Related]
27. A population-based study on substance abuse treatment for adults with disabilities: access, utilization, and treatment outcomes. Krahn G, Deck D, Gabriel R, Farrell N. Am J Drug Alcohol Abuse; 2007 Dec; 33(6):791-8. PubMed ID: 17994475 [Abstract] [Full Text] [Related]
28. Qualitative evaluation of a novel contingency management-related intervention for patients receiving supervised injectable opioid treatment. Neale J, Tompkins CN, Strang J. Addiction; 2016 Apr; 111(4):665-74. PubMed ID: 26498274 [Abstract] [Full Text] [Related]
29. Six-month trial of bupropion with contingency management for cocaine dependence in a methadone-maintained population. Poling J, Oliveto A, Petry N, Sofuoglu M, Gonsai K, Gonzalez G, Martell B, Kosten TR. Arch Gen Psychiatry; 2006 Feb; 63(2):219-28. PubMed ID: 16461866 [Abstract] [Full Text] [Related]
31. A randomized clinical trial of a new behavioral treatment for drug abuse in people with severe and persistent mental illness. Bellack AS, Bennett ME, Gearon JS, Brown CH, Yang Y. Arch Gen Psychiatry; 2006 Apr; 63(4):426-32. PubMed ID: 16585472 [Abstract] [Full Text] [Related]